CytoSolve, Inc. is a leading biotechnology company based in Cambridge, MA. They collaborate with renowned scientists and research institutions to develop large-scale systems architecture and models of disease and complex biological phenomena. Their innovative approach, known as the CytoSolve approach, aims to revolutionize the field of precision personalized medicine by using in silico mechanistic modeling to study phenomena that are not possible through traditional in vitro and in vivo experiments. Additionally, CytoSolve is involved in the development of functional food dietary supplements and cosmetics, with a focus on reducing toxicity and risk while providing effective and safe products.
Generated from the website